Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Vascular Solutions Inc Raises Low End Of Prior FY 2013 Revenue Guidance; Reaffirms FY 2013 EPS Guidance; Issues Q3 2013 Guidance In Line With Analysts' Estimates


Tuesday, 23 Jul 2013 04:05pm EDT 

Vascular Solutions Inc announced that for fiscal 2013, it is raising the low end of revenue guidance to a range of between $107 million and $110 million. Previously, the Company's revenue guidance was a range of $106 million to $110 million. Vascular Solutions continues to expect 2013 net earnings, adjusted to exclude the effects of the Guardian product recall during the first quarter, of between $0.66 and $0.70 per fully diluted share. On a GAAP basis, this adjusted earnings guidance corresponds to net earnings of between $0.62 and $0.66 per fully diluted share. Both the adjusted and GAAP earnings per share guidance for 2013 include between $1.3 million and $1.5 million for the U.S. medical device excise tax, and an assumed 36% effective income tax rate. For the third quarter of 2013, Vascular Solutions is providing guidance for net revenue of between $26.5 million and $27.5 million. Net earnings for the third quarter of 2013 are projected to be between $0.16 and $0.17 per fully diluted share (EPS). The Company's net earnings guidance for the third quarter of 2013 includes $800,000 in non-cash stock-based compensation, $400,000 in amortization of intangibles, $350,000 for the U.S. medical device excise tax, and an assumed 38% effective income tax rate. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $108 million and EPS of $0.67 for fiscal 2013; and revenue of $27.0 million and EPS of $0.17 for the third quarter of 2013. 

Company Quote

31.48
-0.02 -0.06%
30 Mar 2015